Your computer doesn't have the Flash Player v.8 plugin installed, so this website can't be properly viewed.
For full experience, please download it at Adobe.comBy clicking on this link, you will be leaving this siteThis link will take you to a site outside of Merck & Co., Inc. Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.
Proceed.
Human papillomavirus (HPV) affects both females and males. HPV transmission can happen with any kind of sexual, genital contact with someone who has HPV—intercourse isn't necessary.
Many people who have HPV don't even know it, since the virus often has no signs or symptoms. That means HPV transmission can happen without anyone knowing it.
There are about 6 million new cases of genital HPV* in the United States each year. It's estimated that 74% of them occur in 15- to 24-year-olds.
*Number represents more than 30 genital HPV types, not just HPV Types 6, 11, 16, and 18.
GARDASIL is the only cervical cancer vaccine that helps protect against 4 types of human papillomavirus (HPV): 2 types that cause 70% of cervical cancer cases, and 2 more types that cause 90% of genital warts cases. GARDASIL is for girls and young women ages 9 to 26.
Anyone who is allergic to the ingredients of GARDASIL should not receive the vaccine. GARDASIL is not for women who are pregnant. GARDASIL does not treat cervical cancer or genital warts.
GARDASIL may not fully protect everyone, and does not prevent all types of cervical cancer, so it’s important to continue routine cervical cancer screenings. GARDASIL will not protect against diseases caused by other HPV types or against diseases not caused by HPV.
The side effects include pain, swelling, itching, and redness at the injection site, fever, nausea, dizziness, vomiting, and fainting. GARDASIL is given as 3 injections over 6 months.
Only a doctor or healthcare professional can decide if GARDASIL is right for you or your daughter.
Read the Patient Product Information or the Prescribing Information for GARDASIL.
This site is intended only for residents of the United States, its territories, and Puerto Rico.
GARDASIL is a registered trademark of Merck & Co., Inc.
20802636(2)-03/08-GRD